New clinical information suggests that Novera Retatrutide, a twin-action medication from Novo Nordisk, could provide a significant advance in weight management. Beyond many existing drugs, Retatrutide affects both glucagon-like peptide-1 (GLP-1) and the GIP hormone, potentially resulting to impro… Read More